Tradestie Institutional Equity Comparison Engine

BLFS vs EKSO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-10-05 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BLFS Overall Edge

BLFS Captures Institutional Edge (3โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioLife Solutions Inc. (BLFS) driven by superior Valuation, Growth & Margin, Options & Structure while EKSO counters with relative strength in Momentum & Technical. Fundamentally, BLFS trades at 117.0x Forward P/E with 6.0% operating margin (+21.5% YoY revenue) versus EKSO at N/M Forward P/E and -119.7% operating margin (-38.3% YoY). In options structure, BLFS sits in BREAKOUT (6th %ile IV; Dealer Gamma Walls on Pro) against EKSO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BLFS
BLFS 117.0x vs EKSO N/M Fwd P/E
Growth & Margin Winner BLFS
Op Margin 6.0% vs -119.7% ยท YoY +21.5% vs -38.3%
Momentum & Technical Winner EKSO
1Y +49.0% vs +62.6% ยท 52W Pos 95% vs 87%
Options & Structure Winner BLFS
BREAKOUT (6th %ile IV) vs UNCLASSIFIED (N/A IV)
BLFS NASDAQ
BioLife Solutions Inc.
Electromedical & Electrotherapeutic Apparatus
$38.61
+3.51% 1D
Market Cap $1.8B
1M Return +8.67%
1Y Return +49.02%
Forward P/E 117.0x
Unified AI Score
46.0 / 100 HOLD
Tech 27.0 Fund 46.0 Flow 59.0 Mom 56.0
EKSO NASDAQ
Ekso Bionics Holdings, Inc. Common Stock
General Industrial Machinery & Equipment, Nec
$11.80
+0.08% 1D
Market Cap $42.0M
1M Return +25.53%
1Y Return +62.6%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BLFS +49.02% EKSO +62.6% Spread: +140.4 pp (EKSO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BLFS TTM Op. Margin: 6.0% EKSO TTM Op. Margin: -119.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BLFS vs EKSO. Trailing 12-month operating profitability (BLFS 6.0% vs EKSO -119.7%) and valuation multiples (BLFS 117.0x vs EKSO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BLFS (9) vs EKSO (1)
Institutional Metric BLFS EKSO Criterion Row Winner
Market Capitalization Scale $1.8B $42.0M Larger Scale BLFS
Trailing P/E Ratio Valuation 37.3x N/M Lower Multiple BLFS
Forward P/E Ratio Valuation 117.0x N/M Lower Multiple BLFS
Revenue Growth (YoY) Growth +21.5% -38.3% Higher Growth BLFS
Operating Margin (TTM) Profitability 6.0% -119.7% Higher Margin BLFS
Net Profit Margin Profitability 54.4% -91.4% Higher Margin BLFS
Return on Equity (ROE) Capital Efficiency 12.8% -107.6% Higher ROE BLFS
52-Week Range Position Momentum 95% ($18โ€“$40) 87% ($0โ€“$14) Stronger Trend BLFS
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 31% Vol 2.16ฮฒ ยท 76% Vol Lower Realized Risk BLFS
Unified Institutional Score Composite Signal 46.0 / 100 (HOLD) 58.1 / 100 (HOLD) Higher Composite EKSO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BLFS vs EKSO Buy Guide
BLFS BREAKOUT
38d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live BLFS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EKSO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EKSO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BLFS nor EKSO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.